Changing China Is Opening Up For Health Care Entrants
Market And Demographic Changes Are A Force For Reform
Executive Summary
The potential of China’s vast health care products market is alluring. It has proved off-limits to most of the global medtech industry, and is rarely in the early launch strategies of global companies. Government-led initiatives want that to change, as evidenced in the latest Five-Year Plan and the recent Healthy China 2030 report.
You may also be interested in...
The China Honeymoon Is Over: Global Medtech Must Think Decisively
China is transitioning to an economy driven by innovation and technology, with differential effects on foreign medtechs depending on their place in the value chain and type of innovation. China commentators have been updating the market.
View From German Industry: MDR At The Turning Point
Spectaris’ Marcus Kuhlmann describes Medica as a valued hub to meet member companies and host ecosystem and trade updates for the wider medtech industry. The German industry association’s medtech leader spoke to Medtech Insight during the 2022 event about the top concerns for manufacturers.
On-Prescription Apps Are Just One Vital Part Of Germany’s Digital Strategy
Are too few digital health care apps approved for reimbursement in Germany? That’s not the point, says the health care ministry, urging a look at the bigger strategic picture.